Loss of H3K27me3 Imprinting in Somatic Cell Nuclear Transfer Embryos Disrupts Post-Implantation Development

Cell Stem Cell
Shogo MatobaYi Zhang

Abstract

Animal cloning can be achieved through somatic cell nuclear transfer (SCNT), although the live birth rate is relatively low. Recent studies have identified H3K9me3 in donor cells and abnormal Xist activation as epigenetic barriers that impede SCNT. Here we overcome these barriers using a combination of Xist knockout donor cells and overexpression of Kdm4 to achieve more than 20% efficiency of mouse SCNT. However, post-implantation defects and abnormal placentas were still observed, indicating that additional epigenetic barriers impede SCNT cloning. Comparative DNA methylome analysis of IVF and SCNT blastocysts identified abnormally methylated regions in SCNT embryos despite successful global reprogramming of the methylome. Strikingly, allelic transcriptomic and ChIP-seq analyses of pre-implantation SCNT embryos revealed complete loss of H3K27me3 imprinting, which may account for the postnatal developmental defects observed in SCNT embryos. Together, these results provide an efficient method for mouse cloning while paving the way for further improving SCNT efficiency.

Citations

Nov 2, 2018·Proceedings of the National Academy of Sciences of the United States of America·Dawei YuSen Wu
Jan 24, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chuan ZhouYong Zhang
May 6, 2019·Cell Cycle·Jianping Guo, Wenyi Wei
Oct 17, 2019·Cold Spring Harbor Perspectives in Biology·Melanie D White, Nicolas Plachta
Oct 28, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Lei YangGuangpeng Li
Feb 8, 2019·Reproduction : the Official Journal of the Society for the Study of Fertility·Chengfa ZhaoZhenfang Wu
Feb 20, 2020·Stem Cell Research & Therapy·Pengxiang QuEnqi Liu
Feb 13, 2019·The Journal of Reproduction and Development·Kei Miyamoto
Jun 10, 2020·Nature Reviews. Genetics·Zhiyuan Chen, Yi Zhang
Dec 14, 2019·Nature Communications·Aaron B BogutzLouis Lefebvre
Aug 28, 2020·Frontiers in Cell and Developmental Biology·Meng ZhangZiyi Li
Nov 16, 2020·The FEBS Journal·Dilşad H ArabacıTamer T Önder
Apr 26, 2020·Methods : a Companion to Methods in Enzymology·Saori Mizuno-IijimaFumihiro Sugiyama
Jan 29, 2020·Theriogenology·Atsuo Ogura
Jan 1, 2021·International Journal of Molecular Sciences·Kilian SimmetValeri Zakhartchenko
Feb 16, 2021·Frontiers in Cell and Developmental Biology·Nariaki NakamuraYong Li
Nov 14, 2020·ELife·Iromi WanigasuriyaMarnie E Blewitt
May 13, 2021·Journal of Radiation Research·Kento MiuraOsamu Kaminuma
Jun 3, 2021·Genes & Development·Courtney W Hanna, Gavin Kelsey
Jun 1, 2021·Current Opinion in Genetics & Development·Eva Hörmanseder
Jul 1, 2021·Biology of Reproduction·Mingtian DengFeng Wang
Jul 27, 2021·Trends in Genetics : TIG·Maximilian W D RaasHendrik Marks
Aug 8, 2021·International Journal of Molecular Sciences·Chunshen LongYongchun Zuo
Sep 30, 2021·Cell Cycle·Deling JiaoHong-Jiang Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.